[Natural immune system cells and perspectives to develop recombinant proteins with microbial activity].
Egorov
A M
AM
SAzykin
I O
IO
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D007107:Immune System / Q000166:cytology*; D008050:Lipid A / Q000378:metabolism; D008565:Membrane Proteins; D009504:Neutrophils / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology
D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D008050:Lipid A; D008565:Membrane Proteins; D011994:Recombinant Proteins; C021623:bactericidal permeability increasing protein